Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
27
06
2019
revised:
06
09
2019
accepted:
23
09
2019
pubmed:
24
10
2019
medline:
22
9
2020
entrez:
24
10
2019
Statut:
ppublish
Résumé
The precise pathogenesis or neural correlates underlying levodopa-induced dyskinesia (LID) remains poorly understood. There is growing evidence of the involvement of the cerebellum in Parkinson's disease (PD). The present study evaluated the role of motor cerebellar connectivity in determining vulnerability to LID. We enrolled 25 de novo patients with PD who developed LID within 5 years of levodopa treatment, 26 propensity score-matched PD patients who had not developed LID, and 24 age- and sex-matched healthy controls. We performed a comparative analysis of resting-state functional connectivity (FC) between the motor cerebellum and whole brain between the groups. The patients with PD had increased FC bewteen the motor cerebellum and posterior cortical and cerebellar regions, while no gray matter regions had decreased FC with the motor cerebellum compared to the control participant. The patients with PD who were vulnerable to the development of LID had a significantly higher FC between the motor cerebellum lobule VIIIb and the left inferior frontal gyrus than those who were resistant to LID development. The connectivity of the motor cerebellum and left inferior frontal gyrus was negatively correlated with the latency from PD onset to the occurrence of LID. Increased FC between the motor cerebellum and left inferior frontal gyrus in de novo patients with PD could be an important determinant of vulnerability to LID.
Identifiants
pubmed: 31643140
doi: 10.1002/acn3.50918
pmc: PMC6856615
doi:
Substances chimiques
Antiparkinson Agents
0
Levodopa
46627O600J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2251-2260Subventions
Organisme : National Research Foundation of Korea
ID : NRF-2016R1A2A2A05920131
Pays : International
Organisme : Ministry of Science, ICT and Future Planning
ID : 2016R1A2B3016609
Pays : International
Informations de copyright
© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Références
Mov Disord. 2016 May;31(5):755-9
pubmed: 26861941
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Am Health Drug Benefits. 2012 Sep;5(6):347-58
pubmed: 24991332
Front Hum Neurosci. 2015 Apr 21;9:214
pubmed: 25954184
Mov Disord. 2011 Apr;26(5):807-12
pubmed: 21384430
Hum Brain Mapp. 2015 Jan;36(1):199-212
pubmed: 25164875
Hum Brain Mapp. 2014 Jul;35(7):3152-69
pubmed: 24142505
Hum Brain Mapp. 2009 May;30(5):1502-10
pubmed: 18649351
Brain. 2013 Mar;136(Pt 3):696-709
pubmed: 23404337
Neuroimage. 2010 Apr 15;50(3):1313-9
pubmed: 20056157
Neurology. 2009 Jul 14;73(2):113-9
pubmed: 19597133
Neurology. 2003 Feb 25;60(4):612-9
pubmed: 12601101
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):423-431
pubmed: 29075830
Cereb Cortex. 2013 Feb;23(2):305-14
pubmed: 22351647
J Neurosci. 2003 Sep 10;23(23):8432-44
pubmed: 12968006
Ann Neurol. 2010 Dec;68(6):816-24
pubmed: 21194152
BMC Neurosci. 2008 Oct 21;9:102
pubmed: 18939997
Mov Disord. 2007 Jul 30;22(10):1379-89; quiz 1523
pubmed: 17427940
Neuroimage. 2009 May 15;46(1):39-46
pubmed: 19457380
J Parkinsons Dis. 2015;5(3):569-74
pubmed: 26406137
Neuroimage. 2009 Jan 15;44(2):489-501
pubmed: 18835452
Comput Biomed Res. 1996 Jun;29(3):162-73
pubmed: 8812068
Handb Clin Neurol. 2018;154:59-70
pubmed: 29903452
Psychiatry Res. 2013 Jan 30;211(1):64-71
pubmed: 23352277
Neurology. 2006 Apr 25;66(8):1192-9
pubmed: 16636237
Mov Disord. 1987;2(2):73-91
pubmed: 3504266
Brain. 2005 Oct;128(Pt 10):2250-9
pubmed: 15958505
Mov Disord. 2001 May;16(3):448-58
pubmed: 11391738
J Neurochem. 2006 Oct;99(2):381-92
pubmed: 16942598
Mov Disord. 2016 Apr;31(4):521-9
pubmed: 26954295
Mov Disord. 2012 Mar;27(3):364-71
pubmed: 22076870
Brain. 2016 Mar;139(Pt 3):845-55
pubmed: 26794597
J Cereb Blood Flow Metab. 2004 Jan;24(1):7-16
pubmed: 14688612
Int J Biomed Imaging. 2008;2008:372125
pubmed: 18274665
Clin Neurophysiol. 2017 Jun;128(6):992-999
pubmed: 28454042
Nat Neurosci. 2005 Nov;8(11):1491-3
pubmed: 16205719
Eur Neurol. 2008;60(2):57-66
pubmed: 18480609
Cereb Cortex. 2009 Oct;19(10):2485-97
pubmed: 19592571